Saama’s Jonathan Burr Talks with DPharm about Accelerating Clinical Development
Increased amounts of data and greater complexity have driven drug development costs and timelines way up over the past 20 years, but events like COVID-19 have demonstrated the need for sustainable speed and efficiency.
In this DPharm Newsletter interview, Saama’s Senior VP of Clinical Platform Strategy explains how data integration, artificial intelligence (AI), and the constant application of innovation to solve client problems and change outdated ways of working are transforming the drug development industry.
